Pharos iBio Co., Ltd. (KOSDAQ: 388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,440.00
-360.00 (-4.62%)
Dec 20, 2024, 9:00 AM KST

Pharos iBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
96,206191,588----
Enterprise Value
79,151164,210----
Last Close Price
7440.0014830.00----
PB Ratio
4.726.76----
P/TBV Ratio
5.616.79----
Debt / Equity Ratio
0.010.010.02-0.04-0.68-0.33
Asset Turnover
--0.010.000.02-
Quick Ratio
28.6021.1516.060.560.860.59
Current Ratio
29.3221.5716.530.570.880.64
Return on Equity (ROE)
-42.03%-38.50%-1825.61%---
Return on Assets (ROA)
-28.70%-26.12%-28.73%-23.78%-32.64%-
Return on Capital (ROIC)
-29.47%-27.09%-469.65%---
Earnings Yield
-11.15%-4.62%----
FCF Yield
-9.43%-4.31%----
Buyback Yield / Dilution
-10.01%-36.26%-53.03%-2.65%-1.86%-
Total Shareholder Return
-10.01%-36.26%-53.03%-2.65%-1.86%-
Source: S&P Capital IQ. Standard template. Financial Sources.